CIK 1397144
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2022-Q3. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Pharmaceuticals & Biotechnology | 63.08% | 7 |
| Unclassified | 36.92% | 12 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | PCVX | Vaxcyte, Inc. | Health Care | 31.54% |
| 2 | VERONA PHARMA PLC | Unclassified | 20.92% | |
| 3 | VERA | Vera Therapeutics, Inc. | Health Care | 18.66% |
| 4 | HILLEVAX INC COM | Unclassified | 10.02% | |
| 5 | ACET | Adicet Bio, Inc. | Health Care | 6.16% |
| 6 | PHAT | Phathom Pharmaceuticals, Inc. | Health Care | 5.25% |
| 7 | RENEO PHARMACEUTICALS INC | Unclassified | 1.57% | |
| 8 | SIENTRA INC | Unclassified | 1.11% | |
| 9 | JASPER THERAPEUTICS INC | Unclassified | 0.89% | |
| 10 | SOLENO THERAPEUTICS INC | Unclassified | 0.78% |
7/19 names classified · sector 63.1% of weight · industry 63.1% · mkt cap 62.4%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 63.1% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/8 names) · unclassified 100.0%: , PCVX, VERA, ACET, PHAT, NCNA, SPRB, XCUR. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | PCVXVAXCYTE INC | 2,019,057 | $97M | 31.5% | TRIM −52% |
| 2 | VERONA PHARMA PLC | 2,457,500 | $64M | 20.9% | HOLD |
| 3 | VERAVERA THERAPEUTICS INC | 2,960,231 | $57M | 18.7% | HOLD |
| 4 | HILLEVAX INC COM | 1,838,486 | $31M | 10.0% | HOLD |
| 5 | ACETADICET BIO INC | 2,115,385 | $19M | 6.2% | HOLD |
| 6 | PHATPHATHOM PHARMACEUTICALS INC | 1,435,106 | $16M | 5.2% | HOLD |
| 7 | RENEO PHARMACEUTICALS INC | 2,073,957 | $5M | 1.6% | HOLD |
| 8 | SIENTRA INC | 1,673,589 | $3M | 1.1% | HOLD |
| 9 | JASPER THERAPEUTICS INC | 5,628,558 | $3M | 0.9% | HOLD |
| 10 | SOLENO THERAPEUTICS INC | 1,201,506 | $2M | 0.8% | HOLD |
| 11 | NCNANUCANA PLC | 3,333,333 | $2M | 0.7% | HOLD |
| 12 | EFFECTOR THERAPEUTICS INC | 4,822,114 | $2M | 0.7% | HOLD |
| 13 | SPRBSPRUCE BIOSCIENCES INC | 1,792,518 | $2M | 0.6% | HOLD |
| 14 | PARATEK PHARMACEUTICALS INC | 1,041,131 | $2M | 0.6% | HOLD |
| 15 | CYMABAY THERAPEUTICS INC | 131,036 | $821,596 | 0.3% | HOLD |
| 16 | XCUREXICURE INC | 281,636 | $323,881 | 0.1% | HOLD |
| 17 | AEGLEA BIOTHERAPEUTICS INC | 240,500 | $108,225 | 0.0% | HOLD |
| 18 | MOLECULAR TEMPLATES INC | 200,000 | $66,000 | 0.0% | HOLD |
| 19 | OBSEVA SA | 87,999 | $12,760 | 0.0% | HOLD |
Where this firm's principals came from and which firms its alumni went on to found.
